ArticleCureus2025
Cerebral Venous Thrombosis in Pediatric Oncology: A Case of Burkitt Lymphoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral venous thrombosis (CVT) is an uncommon but serious complication in pediatric patients with cancer. We report the case of a nine-year-old boy diagnosed with Burkitt lymphoma involving the nasopharyngeal region, who developed superior sagittal sinus thrombosis during chemotherapy. Neurological examination prior to treatment revealed no signs of intracranial hypertension. However, two weeks after completing the first course of chemotherapy, the patient presented with severe headaches and intermittent vomiting. Neuroimaging confirmed cerebral venous thrombosis, while the tumor mass was regressing. Anticoagulant therapy with low-molecular-weight heparin was initiated and carefully adjusted in response to chemotherapy-induced thrombocytopenia. Clinical evolution was favorable, with complete neurological recovery and radiological resolution of the thrombus. This case emphasizes the importance of early recognition of CVT in pediatric oncology, especially when neurological symptoms occur during chemotherapy, even in the absence of prior intracranial hypertension. It also highlights the challenges of anticoagulant management in the context of treatment-related thrombocytopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.